Spherix Global Insights
Spherix Global Insights Spherix Global Insights is a newly established business intelligence and market research company with US offices in both Malvern, PA and Cambridge, MA, and a European office in Zug, Switzerland. Our approach is to apply our commercial experience and unique relationships within core specialty markets to translate data into insight, enabling our clients to make smarter business decisions.
-
-
-
-
-
-
-
Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Market
-
-
-
-
-
-
-
IgA Nephropathy Pipeline Dynamics Signal Further Treatment Evolution on the Horizon
-
-
-
-
-
-
-
Stakes Are High for Regeneron's Eylea HD as Genentech's Vabysmo Continues to Gain Momentum, Prompting Doctors to Weigh Their Options Between Two Industry Titans, According to Spherix Global Insights
-
-
-
-
-
-
-
US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Halting Neurodegeneration as Leading Treatment Priority
-
-
-
-
-
-
-
Eli Lilly's Olumiant and Pfizer's Litfulo Strengthen Alopecia Areata Arsenal, Yet Resounding Opportunity for JAK Expansion and New Assets in Development Remain
-
-
-
-
-
-
-
US Nephrologists Embrace Current IgA Nephropathy Therapies, Yet a Thriving Pipeline Signals Fierce Market Evolution Ahead
-
-
-
-
-
-
-
Another Medicine to Stop Migraine in its Tracks – Zavzpret™ is Now Available, but Where will Neurologists use it?
-
582 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
